Nichi BRITE β-葡聚糖作為輔助胰腺癌治療的營養補充品；日本近森醫院報告了令人鼓舞的臨床結果

<!DOCTYPE html> <html lang="zh_hant" xmlns:wb="//open.weibo.com/wb"> <head> <meta charset="utf-8"> <title>Nichi BRITE β-葡聚糖作為輔助胰腺癌治療的營養補充品；日本近森醫院報告了令人鼓舞的臨床結果 - 美國商業資訊</title> <meta name="viewport" content="width=device-width, initial-scale=1.0"> <meta name="description" content="東京--(BUSINESS WIRE)--(美國商業資訊)-- 服用Nichi BRITE &beta;-葡聚糖可提高免疫力，進而降低接受惡性胰腺腫瘤手術切除病患的胰腺癌生物標記及其復發率，這一發現在日本橫濱舉行的ASCO&reg; Breakthrough會議上進行了呈報。在胃腸外科"> <meta name="keywrods" content=""> <meta name="author" content="Business Wire China"> <link href="/css/bootstrap.css" rel="stylesheet"> <link href="/css/main.css?ver=20220804" rel="stylesheet"> <link href="/css/bootstrap-responsive.css" rel="stylesheet"> <script type="text/javascript" src="/js/jquery.min.js"></script> <script type="text/javascript" src="/js/bootstrap.js"></script> <script type="text/javascript" src="/js/main.js"></script>  <script src="//tjs.sjs.sinajs.cn/open/api/js/wb.js" type="text/javascript" charset="utf-8"></script> </head> <body>  <div class="header"> <div class="wrap"> <div class="container"> <div class="full_980 relative">  <div class="top_panel visible-desktop"> <a href="/zh">简体中文</a> | <a href="/hk">繁體中文</a> | <a href="/en">English</a> <div class="globalsite"><select id="globalsite" class="languages"><option value="0">美國商業資訊全球站點</option> <option value="1">Business Wire Global</option><option value="3">UK/Ireland</option><option value="4">Deutschland</option><option value="5">France</option><option value="6">Italy</option><option value="7">Japan</option> </select> </div> </div> <div class="logo"><a href="/hk"><img src="/images/bwlogo_webmain_china.png" alt="美國商業資訊" width="360" height="80"/></a></div> <div class="clear"></div> <div class="navigation"> <ul class="sf-menu"> <li class="current"><a href="/hk">首頁</a> </li> <li><a href="/hk/news/index.html">新聞稿中心</a> </li> <li><a href="/hk/events/index.html">會展信息</a> </li> <li><a href="/hk/medias/index.html">媒體合作</a> </li> <li><a href="/hk/about/index.html">美國商業資訊</a> <ul> <li><a href="/hk/about/contact.html">聯絡我們</a></li> </ul> </li> </ul> <div class="clear"></div>  <div class="search_form visible-desktop"> <form action="/hk/news/search" method="get"> <input class="inp_search" name="s" type="text" value="搜索..." title="搜索..." /> <input type="submit" class="search_btn" value=" " /> </form> </div>  </div>  </div> </div> </div> </div>   <div class="page_wrapper"> <div class="wrap"> <div class="container"> <div id="content"> <script src="http://tjs.sjs.sinajs.cn/open/api/js/wb.js?appkey=3616646312" type="text/javascript" charset="utf-8"></script> <script type="text/javascript" src="/js/swfobject.js"></script> <div class="full_980 main_wrap"> <div class="row"> <div class="span9 main_block story"> <p><img src="/files/logos/N/Nichi_brite_Onco_Nutrition.jpg" alt="Nichi BRITE"></p> <h2 class="storytitle">Nichi BRITE β-葡聚糖作為輔助胰腺癌治療的營養補充品；日本近森醫院報告了令人鼓舞的臨床結果</h2> <div class="storytimelang"> <span class="time">2024-08-09 14:40</span> <span class="lang"> <ul> <li><a href="/zh/news/57455.html"><img src="/images/zh_cn.png" alt="zh_cn"></a></li> <li><a href="/hk/news/57455.html"><img src="/images/zh_hant.png" alt="zh_hant"></a></li> <li><a href="/en/news/57455.html"><img src="/images/en.png" alt="en"></a></li> </ul> </span> <div class="clear"></div> </div> <ul class="industry-list"> <li><a href="/hk/industry/health-pharmaceutical.html" class="btn">醫藥和健康</a></li> </ul> <div class="storycontent"> <div itemprop="articleBody"> <p> 東京--(<span itemid="https://www.businesswire.com" itemprop="provider publisher copyrightHolder" itemscope="itemscope" itemtype="https://schema.org/Organization"><span itemprop="name"><a href="https://www.businesswire.com/" itemprop="url" referrerpolicy="unsafe-url" rel="nofollow">BUSINESS WIRE</a></span></span>)--(美國商業資訊)-- 服用Nichi BRITE β-葡聚糖可提高免疫力，進而降低接受惡性胰腺腫瘤手術切除病患的胰腺癌生物標記及其復發率，這一發現在<a href="https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fmeetings.asco.org%2Fabstracts-presentations%2F239303&esheet=54106400&newsitemid=20240807426641&lan=zh-HK&anchor=%26%2326085%3B%26%2326412%3B%26%2327243%3B%26%2328657%3B%26%2333289%3B%26%2334892%3B%26%2330340%3BASCO%26%23174%3B+Breakthrough%26%2326371%3B%26%2335696%3B&index=1&md5=3e2a1265071abb03c37e292fecc4ddc3" referrerpolicy="unsafe-url" rel="nofollow" shape="rect" target="_blank">日本橫濱舉行的ASCO® Breakthrough會議</a>上進行了呈報。在胃腸外科醫生和日本高知縣<a href="https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.chikamori.com%2Fabout%2Ftraining%2Fnst%2F&esheet=54106400&newsitemid=20240807426641&lan=zh-HK&anchor=%26%2336817%3B%26%2326862%3B%26%2337291%3B%26%2338498%3B%26%2329151%3B%26%2339178%3B%26%2325903%3B%26%2325588%3B%26%2323567%3B%26%2332068%3B&index=2&md5=d7f5a96d6c83c7d31b176c9f3c87c18b" referrerpolicy="unsafe-url" rel="nofollow" shape="rect" target="_blank">近森醫院營養支援小組</a>的研究中，相較對照組，給藥Nichi BRITE的病患的免疫標記IgA和CD209得到強化，而胰腺癌標記CA19-9和癌症復發和嚴重程度標記CD44則顯著降低。重要的是，Nichi BRITE給藥後，平均生存期得到了改善。</p> <p> 胰腺癌的預後非常差。早期資料顯示，Nichi BRITE無過敏原食品補充品在<a href="https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fdoi.org%2F10.1080%2F21645515.2021.1880210&esheet=54106400&newsitemid=20240807426641&lan=zh-HK&anchor=%26%2325913%3B%26%2321892%3B%26%2320813%3B%26%2330123%3B%26%2331995%3B%26%2332113%3B&index=3&md5=757f81e38f8d2e320d45931bec93b8ed" referrerpolicy="unsafe-url" rel="nofollow" shape="rect" target="_blank">改善免疫系統</a>、縮小動物模型中的腫瘤以及強化健康志工、老年人和癌症病患NK細胞的毒殺功能方面表現出良好的安全性和有效性，這些資料<a href="https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fdoi.org%2F10.3892%2For.2021.8225&esheet=54106400&newsitemid=20240807426641&lan=zh-HK&anchor=%26%2327083%3B%26%2325104%3B%26%2320102%3B%26%2326412%3B%26%2327425%3B%26%2333256%3B%26%2324202%3B%26%2330740%3B%26%2331350%3B%26%2330340%3B%26%2322522%3B%26%2330990%3B&index=4&md5=197bbd8e5d583bdfc851b40e0df9d677" referrerpolicy="unsafe-url" rel="nofollow" shape="rect" target="_blank">構成了本次臨床研究的基礎</a>。在研究中，病患從手術前一天起至術後第21 天，透過口服或胃造口餵食的方式給藥Nichi BRITE β-葡聚糖。肝膽胰外科首席醫師<a href="https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.chikamori.com%2Fdepartment%2Fshokakigeka%2F%23contents02&esheet=54106400&newsitemid=20240807426641&lan=zh-HK&anchor=Akira+Tsukada%26%2321338%3B%26%2322763%3B&index=5&md5=6065d6223ca5010523ee8668581261cb" referrerpolicy="unsafe-url" rel="nofollow" shape="rect" target="_blank">Akira Tsukada博士</a>指出，使用Nichi BRITE未見不良反應，且效果非常鼓舞人心。</p> <p> 相較對照組，給藥Nichi BRITE組的免疫強化參數有所提高。IgA水準得以提高，這是抵禦感染的第一道防線；CD209水準顯著提高，它代表的是來源於單核細胞的樹突狀細胞，它們呈遞外來抗原以供免疫系統銷毀。研究人員認為，這種免疫功能的強化促成了導致轉移的CD44癌症幹細胞的減少、胰腺癌標記CA19-9的降低以及平均存活期的延長，證實了Nichi BRITE多管齊下的優勢。</p> <p> 在感謝名譽主席Masanori Chikamori博士的倡議和承擔實驗室研究的<a href="https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fresearchmap.jp%2F93-11&esheet=54106400&newsitemid=20240807426641&lan=zh-HK&anchor=%26%2320061%3B%26%2324030%3B%26%2337291%3B%26%2331185%3B%26%2322823%3B%26%2323416%3BNobunao+Ikewaki%26%2325945%3B%26%2325480%3B&index=6&md5=92805747290f6f2507082fe870c901ca" referrerpolicy="unsafe-url" rel="nofollow" shape="rect" target="_blank">九州醫科大學Nobunao Ikewaki教授</a>的同時，他們建議考慮將Nichi BRITE作為輔助癌症治療的傳統營養補充品，納入癌症和其他疾病手術病患的臨床營養指南。</p> <p> <em>Nichi BRITE並非藥物或任何疾病的治療方法，也不附帶任何治療聲明。研究結果僅供專業醫護人員參考，不應視為醫療建議。</em></p> <p> 免責聲明：本公告之原文版本乃官方授權版本。譯文僅供方便瞭解之用，煩請參照原文，原文版本乃唯一具法律效力之版本。</p> </div> <div> <h2> Contacts</h2> <p> Samuel JK Abraham<br /> <a href="mailto:info@gncorporation.com" referrerpolicy="unsafe-url" rel="nofollow" shape="rect" target="_blank">info@gncorporation.com</a></p> </div> <div class="story-image"> <img src="/files/news/54106400-1723185635-1.jpg" alt="Nichi BRITE β-1,3-1,6葡聚糖是由Aureobasidium Pullulans在日本通過GMP認證的工廠生產的胞外多糖，可溶于水。研究中，Nichi BRITE組的受試者每天攝入250毫克β-葡聚糖作為輔助治療的有效成分，連續攝入22 天，而對照組則攝入安慰劑；兩組受試者均接受標準治療。每位病患在研究期間的用量相當於四盒Nichi BRITE，一盒24袋，每袋含1.5克顆粒，其中包含63毫克活性β-葡聚糖成分。當條件允許時，採用口服給藥；當口服給藥不可行時，則透過胃造口或鼻胃管給藥。未觀察到任何不良反應。據報告，使用Nichi Brite作為輔助藥物，在強化免疫力、減少癌症生物標記和延長平均存活期方面具有療效。（圖片：美國商業資訊）"/> <p class="caption">Nichi BRITE β-1,3-1,6葡聚糖是由Aureobasidium Pullulans在日本通過GMP認證的工廠生產的胞外多糖，可溶于水。研究中，Nichi BRITE組的受試者每天攝入250毫克β-葡聚糖作為輔助治療的有效成分，連續攝入22 天，而對照組則攝入安慰劑；兩組受試者均接受標準治療。每位病患在研究期間的用量相當於四盒Nichi BRITE，一盒24袋，每袋含1.5克顆粒，其中包含63毫克活性β-葡聚糖成分。當條件允許時，採用口服給藥；當口服給藥不可行時，則透過胃造口或鼻胃管給藥。未觀察到任何不良反應。據報告，使用Nichi Brite作為輔助藥物，在強化免疫力、減少癌症生物標記和延長平均存活期方面具有療效。（圖片：美國商業資訊）</p> </div> </div> <div class="subjects"> <ul class="subject-list"> <li><a href="/hk/subject/podcast.html">播客新聞</a></li> </ul> </div>  <div id="ckepop"> <span class="jiathis_txt">分享到：    </span> <a class="jiathis_button_tsina"></a> <a class="jiathis_button_tqq"></a> <a class="jiathis_button_renren"></a> <a class="jiathis_button_kaixin001"></a> <a class="jiathis_button_tsohu"></a> <a class="jiathis_button_t163"></a> <a class="jiathis_button_fb"></a> <a class="jiathis_button_googleplus"></a> <a class="jiathis_button_tifeng"></a> <a class="jiathis_button_thexun"></a> <a class="jiathis_button_cnfol"></a> <a class="jiathis_button_txinhua"></a> <a class="jiathis_button_linkedin"></a> <a href="http://www.jiathis.com/share" class="jiathis jiathis_txt jtico jtico_jiathis" target="_blank"></a> </div> <script type="text/javascript" src="http://v3.jiathis.com/code/jia.js?uid=1344225902068353" charset="utf-8"></script> <div class="clear"></div> <wb:comments url="auto" border="y" width="auto" language="zh_tw" skin="blue" appkey="3616646312" ></wb:comments> </div> <div class="span3 sidebar"> <div class="widget"> <h3>美国商业资讯微博</h3> <wb:follow-button uid="2676312451" type="red_2" width="136" height="24" ></wb:follow-button> </div> <div class="widget"> <h3>新闻稿中心</h3> <ul class="industry"> <li><a href="/zh/industry/corporate-social-responsibility">企业社会责任</a></li> <li><a href="/zh/industry/manufacturing">制造业</a></li> <li><a href="/zh/industry/chemical">化工</a></li> <li><a href="/zh/industry/health-pharmaceutical">医药和健康</a></li> <li><a href="/zh/industry/property">建筑和房地产</a></li> <li><a href="/zh/industry/travel">旅游</a></li> <li><a href="/zh/industry/automotive">汽车</a></li> <li><a href="/zh/industry/life-entertainment">生活和娱乐</a></li> <li><a href="/zh/industry/energy-environmental">能源和环境</a></li> <li><a href="/zh/industry/retail">零售</a></li> <li><a href="/zh/industry/transportation">运输和物流</a></li> <li><a href="/zh/industry/business-ecommerce">商务</a></li> <li><a href="/zh/industry/communications-media">通信和传媒</a></li> <li><a href="/zh/industry/metals-mining">金属和矿产</a></li> <li><a href="/zh/industry/finance">金融</a></li> <li><a href="/zh/industry/technology">高科技</a></li> <li><a href="/zh/industry/sports">体育</a></li> <li><a href="/zh/industry/education">教育</a></li> <li><a href="/zh/industry/art-culture">艺术文化</a></li> <li><a href="/zh/industry/legal">法律</a></li> </ul> </div> <div class="widget"> <h3>最新新闻稿</h3> <ul class="story"> <li><span class="time">2024-11-27 17:58</span><br/><a href="/zh/news/58419.html">Philip Morris International Marks a Decade of IQOS—a Milestone in the Journey to a Smoke-Free Future</a></li> <li><span class="time">2024-11-27 12:04</span><br/><a href="/zh/news/58418.html">NTT DATA Announces Intent to Acquire Niveus Solutions to Accelerate Global Leadership in Google Cloud</a></li> <li><span class="time">2024-11-27 11:59</span><br/><a href="/zh/news/58417.html">傳統文化遇見尖端科技：迎賓館赤坂離宮CHRONOSENSE視覺盛宴</a></li> <li><span class="time">2024-11-27 11:53</span><br/><a href="/zh/news/58416.html">Uniphore成為世界經濟論壇的創新者社群成員</a></li> <li><span class="time">2024-11-27 11:47</span><br/><a href="/zh/news/58415.html">阿布達比「科技創新研究所」舉辦「開源人工智慧峰會」，展開有關人工智慧未來的重要討論</a></li> </ul> </div> </div> </div> </div> </div> </div> </div> </div>   <div id="footer" class="hidden-phone"> <div class="wrap"> <div class="container"> <div class="full_980 relative">  <a href="#" id="totop_btn" class="visible-desktop visible-tablet"></a>   <div class="footer_top"> <div class="col940"> <div class="row"> <div class="span4"> <h4>上海</h4> <p class="foot_home">上海市江寧路167號新城大廈1502室</p> <p class="foot_phone">+86 21 5239 8905</p> <p class="foot_email"><a href="mailto:sh@businesswirechina.com">sh@businesswirechina.com</a></p> </div> <div class="span4"> <h4>Business Wire Hong Kong</h4> <p class="foot_home">51/F Hopewell Centre, 183 Queen's Road East<br/>Wan Chai, Hong Kong</p> <p class="foot_phone">+852 3602 3091</p> <p class="foot_email"><a href="mailto:hk@businesswire.com">hk@businesswire.com</a></p> </div> <div class="span4"> <h4 style="text-align: center;text-transform:none;">官方微信：Interfax_China</h4> <p style="text-align: center;"><img src="/images/wechat-bwchina.jpg" style="width:160px" alt="官方微信：Interfax_China"/> </p> </div> </div> </div> </div>   <div class="footer_bottom"> <div class="fleft"> <div class="copyright">© 2008-2016 Interfax Business Wire Services 版权所有，未经许可不得转载。</div> </div> <div class="clear"></div> </div>  </div> </div> </div> </div> <script type="text/javascript"> var _gaq = _gaq || []; _gaq.push(['_setAccount', 'UA-669196-13']); _gaq.push(['_trackPageview']); (function() { var ga = document.createElement('script'); ga.type = 'text/javascript'; ga.async = true; ga.src = ('https:' == document.location.protocol ? 'https://ssl' : 'http://www') + '.google-analytics.com/ga.js'; var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(ga, s); })(); </script> <script language="javascript"> $(document).ready(function() { $("#globalsite").bind("change",function(){ var links = ['','http://www.businesswire.com','http://www.businesswire.ca/','http://www.businesswire.co.uk/','http://www.businesswire.de/','http://www.businesswire.fr/','http://www.businesswire.it/','http://www.businesswire.jp/']; var val = $(this).val(); var link = links[val]; if(link.length>0) { window.open(link); } }); }); </script> </body> </html>

CINXE.COM

Nichi BRITE β-葡聚糖作為輔助胰腺癌治療的營養補充品；日本近森醫院報告了令人鼓舞的臨床結果 - 美國商業資訊